Enovis Corporation reported strong financial results for the fourth quarter and full year 2024, with significant growth in sales and earnings. Fourth-quarter net sales reached $561 million, a 23% increase from the previous year, driven by strong performance in Global Reconstructive and steady execution in Prevention & Recovery. Reconstructive sales grew by 59% on a reported basis, with a 10% increase in comparable sales. The company also reported an adjusted EBITDA of $113 million, or 20% of sales, representing a 210-basis-point improvement over the prior year.

For the full year 2024, Enovis achieved net sales of $2.1 billion, marking a 23% increase from 2023. Reconstructive sales saw a 60% jump, while Prevention & Recovery grew by 2%. Adjusted EBITDA for the year was $377 million, up 210 basis points year over year. Despite these gains, the company posted a net loss from continuing operations of $827 million due to a $645 million goodwill impairment charge.

Enovis has set its financial outlook for 2025, expecting revenue between $2.19 billion and $2.22 billion, with organic revenue growth of 6-6.5%. Adjusted EBITDA is projected to be between $405 million and $415 million, with adjusted earnings per share expected to range from $3.10 to $3.25.

Additionally, the company announced a planned CEO transition, with Matt Trerotola set to retire once a successor is appointed. Enovis continues to focus on integrating recent acquisitions, launching new products, and driving sustainable growth. A conference call to discuss these results is scheduled, with further details available on the company's website.